{"text_format":"3","workbook":"xls","n_sheets":1,"sheets":["Sheet1"],"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"Sheet1","index":0,"n_rows":176,"n_cols":19,"rows_kept":176,"flags":["formulas_cached_only"]}
["招采药品代码","通用名","剂型","规格","包装材质","最小制剂单位","最小包装单位","转换比","批准文号","生产企业","申报企业","是否医保","是否基药","质量层次","申报最小包装价格","挂网结果","挂网目录","批次","备注"]
["XB03AEF286K001010101464","复方肝浸膏糖浆","糖浆剂","复方(200ml)","药用塑料瓶","瓶","盒",1,"国药准字H32026084","江苏泽泰制药有限公司","江苏普华克胜药业有限公司","否","否","其他",298," 符合（独家申报）","阳光目录","2025年第九批药品新增阳光挂网"]
["ZI01AAE0067010105745","二十五味儿茶丸","丸剂","每丸重0.3克","复合膜","丸","盒",24,"国药准字Z54020041","西藏神猴药业有限责任公司","西藏神猴药业有限责任公司","是","否","其他",47.5," 符合（独家申报）","阳光目录","2025年第九批药品新增阳光挂网","专家论证结果"]
["XN05AXA028B015010183036","注射用阿立哌唑微球","注射剂","350mg(按C₂₃H₂₇Cl₂N₃O₂计)","药盒内包括1瓶注射用阿立哌唑微球,1支附带专用溶剂,1个适配器,1支无菌注射针(0.8mmx38mm),1支无菌注射器。注射用阿立哌唑微球:中硼硅玻璃管制注射剂瓶和注射用无菌粉末用卤化丁基橡胶塞(氯化","瓶","盒",1,"国药准字H20250011","珠海市丽珠微球科技有限公司","珠海市丽珠微球科技有限公司","否","否","新化药2类",2200,"符合(视同通过一致性评价仿制药)","阳光目录","2025年第九批药品新增阳光挂网","专家论证结果"]
["XR05CBX169X001020180651","盐酸溴己新口服溶液","口服溶液剂","40ml:80mg","钠钙玻璃模制药瓶,口服药用聚烯烃安全盖。配有带刻度的量杯。","瓶","盒",1,"国药准字H20254392","福元药业有限公司","福元药业有限公司","是","否","通过一致性评价",17.45,"符合(视同通过一致性评价仿制药)","阳光目录","2025年第九批药品新增阳光挂网"]
["XA10BKD256A001010679426","达格列净片","片剂","5mg(按C₂₁H₂₅ClO₆计)","聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片/药用铝箔。","片","盒",30,"国药准字HJ20250029","Hetero Labs Limited","江西省华药医药有限公司","是","是","通过一致性评价",52.36,"符合(视同通过一致性评价仿制药)","阳光目录","2025年第九批药品新增阳光挂网"]
["XD11AXB099F002010184633","吡美莫司乳膏","乳膏剂","1%(15g:0.15g)","铝制药用软膏管","支","盒",1,"国药准字H20244230","华益泰康药业股份有限公司","海南振东生物科技有限公司","是","否","新化药4类",104.37,"符合(视同通过一致性评价仿制药)","阳光目录","2025年第九批药品新增阳光挂网"]
["XD11AXM104T001010183832","米诺地尔搽剂","搽剂","2%(60ml∶1.2g)","外用液体药用高密度聚乙烯瓶","瓶","盒",1,"国药准字H20253979","江苏知原药业股份有限公司","江苏睿实生物科技有限公司","否","否","通过一致性评价",105.5,"符合(视同通过一致性评价仿制药)","阳光目录","2025年第九批药品新增阳光挂网"]
["XD11AXM104T001010383832","米诺地尔搽剂","搽剂","2%(60ml∶1.2g)","外用液体药用高密度聚乙烯瓶","瓶","盒",3,"国药准字H20253979","江苏知原药业股份有限公司","江苏睿实生物科技有限公司","否","否","通过一致性评价",316.5,"符合(视同通过一致性评价仿制药)","阳光目录","2025年第九批药品新增阳光挂网"]
["XJ01DHE007B001010185411","注射用厄他培南钠","注射剂","1.0g(按C₂₂H₂₅N₃O₇S计)","中硼硅玻璃管制注射剂瓶、注射液用氯化丁基橡胶塞6422GS和抗生素瓶用铝塑组合盖包装","瓶","瓶",1,"国药准字HC20250005","Savior Lifetec Corporation Tainan Branch Injection Plant","浙江华润九众医药有限公司","是","否","新化药5.2类",266,"符合(视同通过一致性评价仿制药)","阳光目录","2025年第九批药品新增阳光挂网"]
["XD06AXM119F001010185032","莫匹罗星软膏","软膏剂","2%(15g:0.3g)","铝质药用软膏管包装","支","盒",1,"国药准字H20253011","福元药业有限公司","宣城市众诚医药有限公司","是","是","通过一致性评价",29.27,"符合(视同通过一致性评价仿制药)","阳光目录","2025年第九批药品新增阳光挂网"]
["XJ02ACF059X006010102013","伏立康唑干混悬剂","口服混悬剂","45g:3g,配制成混悬液后伏立康唑浓度为40mg/ml","一个体积为100ml的口服液体药用高密度聚乙烯瓶(带有口服药用高密度聚乙烯压旋盖),内含45g干混悬剂。制成的混悬液体积为75ml,其中可用体积为70ml。还包括一个口服液体药用聚丙烯量杯(最大刻度为","瓶","盒",1,"国药准字H20254249","成都倍特药业股份有限公司","成都倍特药业股份有限公司","是","否","新化药4类",900,"符合(视同通过一致性评价仿制药)","阳光目录","2025年第九批药品新增阳光挂网"]
["XN05ADF085B002010103163","氟哌啶醇注射液","注射剂","1ml:5mg","中硼硅玻璃安瓿(棕色)","支","支",1,"国药准字H20254394","裕松源药业有限公司","裕松源药业有限公司","是","是","新化药3类",13.6,"符合(视同通过一致性评价仿制药)","阳光目录","2025年第九批药品新增阳光挂网"]
["XB05BAC023B002010100469","长链脂肪乳注射液(OO)","注射剂","250ml﹕50g(脂肪)与3g(磷脂)","外阻隔袋三层共挤输液用袋","袋","袋",1,"国药准字H20253759","广东嘉博制药有限公司","广东嘉博制药有限公司","否","否","新化药4类",222.8,"符合(视同通过一致性评价仿制药)","阳光目录","2025年第九批药品新增阳光挂网"]
["XA08ABA209E001010604339","奥利司他胶囊","胶囊剂","60mg","聚氯乙烯/聚偏二氯乙烯固体药用复合硬片和药用铝箔包装","粒","盒",20,"国药准字H20253673","安徽省先锋制药有限公司","安徽省先锋制药有限公司","否","否","通过一致性评价",141.43,"符合(视同通过一致性评价仿制药)","阳光目录","2025年第九批药品新增阳光挂网"]
["XC07FBB249A001010200560","比索洛尔氨氯地平片","片剂","富马酸比索洛尔5mg与苯磺酸氨氯地平(按C₂₀H₂₅CIN₂O₅计)5mg","聚氯乙烯固体药用硬片和药用铝箔,外加聚酯/铝/聚乙烯药用复合膜、袋。","片","盒",30,"国药准字H20254574","天大药业(珠海)有限公司","天大药业(珠海)有限公司","是","否","新化药4类",44.3,"符合(视同通过一致性评价仿制药)","阳光目录","2025年第九批药品新增阳光挂网"]
["XC07FBB249A001010183668","比索洛尔氨氯地平片","片剂","富马酸比索洛尔5mg与苯磺酸氨氯地平(按氨氯地平计)5mg","铝塑包装","片","盒",14,"国药准字H20249788","宁波美诺华天康药业有限公司","安徽博诺美科生物医药有限公司","是","否","通过一致性评价",20.72,"符合(视同通过一致性评价仿制药)","阳光目录","2025年第九批药品新增阳光挂网"]
["XJ05ARY339A001010184134","依非米替片(Ⅰ)","薄膜衣片","每片含依非韦伦0.4g,拉米夫定0.3g,富马酸替诺福韦二吡呋酯0.3g","口服固体药用高密度聚乙烯瓶","片","瓶",30,"国药准字H20233988","上海迪赛诺医药集团股份有限公司,江西迪赛诺医药集团有限公司","上海迪赛诺医药集团股份有限公司","否","否","通过一致性评价",666,"符合(视同通过一致性评价仿制药)","阳光目录","2025年第九批药品新增阳光挂网"]
["XB02BXK018A001020102013","卡络磺钠片","片剂","10mg(按C10H11N4NaO5S·3H2O计)","口服固体药用高密度聚乙烯含热封垫片瓶包装","片","盒",45,"国药准字H20254419","成都倍特药业股份有限公司","成都倍特药业股份有限公司","是","否","新化药3类",45,"符合(视同通过一致性评价仿制药)","阳光目录","2025年第九批药品新增阳光挂网"]
["XC08CAN043X001010105765","尼莫地平口服溶液","口服溶液剂","237ml:1.422g","口服液体药用高密度聚乙烯瓶及儿童安全盖包装。附带口服液体药用聚丙烯量杯。","瓶","盒",1,"国药准字H20253866","海南全星制药有限公司","海南全星制药有限公司","否","否","新化药3类",256,"符合(视同通过一致性评价仿制药)","阳光目录","2025年第九批药品新增阳光挂网"]
["XM03BAM059B002010185013","美索巴莫注射液","注射剂","10ml:1g","中硼硅玻璃安瓿","支","支",1,"国药准字H20254114","成都天台山制药股份有限公司","广州合和医药有限公司","否","否","新化药3类",95.8,"符合(视同通过一致性评价仿制药)","阳光目录","2025年第九批药品新增阳光挂网"]
["XA10BKD256A001020379426","达格列净片","片剂","10mg(按C₂₁H₂₅ClO₆计)","聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片/药用铝箔。","片","盒",10,"国药准字HJ20250030","Hetero Labs Limited","江西省华药医药有限公司","是","是","新化药5.2类",30.89,"符合(视同通过一致性评价仿制药)","阳光目录","2025年第九批药品新增阳光挂网"]
["XA10BDE086A001010309665","二甲双胍恩格列净片(VI)","片剂","每片含盐酸二甲双胍1000mg与恩格列净12.5mg","聚氯乙烯/聚偏二氯乙烯固体药用复合硬片和药用铝箔包装","片","盒",30,"国药准字H20254625","常州市阳光药业有限公司","常州市阳光药业有限公司","是","否","新化药4类",45.45,"符合(视同通过一致性评价仿制药)","阳光目录","2025年第九批药品新增阳光挂网"]
["XA10BDE086A001010209665","二甲双胍恩格列净片(VI)","片剂","每片含盐酸二甲双胍1000mg与恩格列净12.5mg","聚氯乙烯/聚偏二氯乙烯固体药用复合硬片和药用铝箔包装","片","盒",20,"国药准字H20254625","常州市阳光药业有限公司","常州市阳光药业有限公司","是","否","新化药4类",30.75,"符合(视同通过一致性评价仿制药)","阳光目录","2025年第九批药品新增阳光挂网"]
["XA10BDE082A001010209665","二甲双胍恩格列净片(I)","片剂","每片含盐酸二甲双胍500mg与恩格列净5mg","聚氯乙烯/聚偏二氯乙烯固体药用复合硬片和药用铝箔包装","片","盒",60,"国药准字H20254623","常州市阳光药业有限公司","常州市阳光药业有限公司","是","否","新化药4类",53.8,"符合(视同通过一致性评价仿制药)","阳光目录","2025年第九批药品新增阳光挂网"]
["XA10BDE082A001010309665","二甲双胍恩格列净片(I)","片剂","每片含盐酸二甲双胍500mg与恩格列净5mg","聚氯乙烯/聚偏二氯乙烯固体药用复合硬片和药用铝箔包装","片","盒",30,"国药准字H20254623","常州市阳光药业有限公司","常州市阳光药业有限公司","是","否","新化药4类",27.59,"符合(视同通过一致性评价仿制药)","阳光目录","2025年第九批药品新增阳光挂网"]
["XC09DBT195A001010309665","替米沙坦氨氯地平片(II)","片剂","每片含替米沙坦40mg与苯磺酸氨氯地平5mg(按C₂₀H₂₅ClN₂O₅计)","聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片和药用铝箔包装","片","盒",7,"国药准字H20254352","常州市阳光药业有限公司","常州市阳光药业有限公司","否","否","新化药4类",41.33,"符合(视同通过一致性评价仿制药)","阳光目录","2025年第九批药品新增阳光挂网"]
["XC09DBT176A001010209665","替米沙坦氨氯地平片","片剂","每片含替米沙坦80mg与苯磺酸氨氯地平5mg(按C₂₀H₂₅ClN₂O₅计)","聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片和药用铝箔包装","片","盒",14,"国药准字H20254351","常州市阳光药业有限公司","常州市阳光药业有限公司","是","否","新化药4类",95.53,"符合(视同通过一致性评价仿制药)","阳光目录","2025年第九批药品新增阳光挂网"]
["XC07FBB249A001010384221","比索洛尔氨氯地平片","片剂","富马酸比索洛尔5mg与苯磺酸氨氯地平(按C₂₀H₂₅ClN₂O₅计)5mg","聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片和药用铝箔包装","片","盒",30,"国药准字H20254303","浙江赛默制药有限公司","浙江高跖医药科技股份有限公司","是","否","通过一致性评价",43.98,"符合(视同通过一致性评价仿制药)","阳光目录","2025年第九批药品新增阳光挂网"]
["XC07FBB249A001010184135","比索洛尔氨氯地平片","片剂","富马酸比索洛尔5mg与苯磺酸氨氯地平(按C₂₀H₂₅ClN₂O₅计)5mg","聚氯乙烯固体药用硬片及药用铝箔包装","片","盒",30,"国药准字H20254304","华益药业科技(安徽)有限公司","杭州沐源生物医药科技有限公司","是","否","新化药4类",44.24,"符合(视同通过一致性评价仿制药)","阳光目录","2025年第九批药品新增阳光挂网"]
["XC07AGL005B002010283793","盐酸拉贝洛尔注射液","注射剂","10ml:50mg","中硼硅玻璃安瓿","支","支",1,"国药准字H20254451","江苏神龙药业有限公司","南京斯泰尔医药科技有限公司","否","否","新化药3类",398,"符合(视同通过一致性评价仿制药)","阳光目录","2025年第九批药品新增阳光挂网"]
["XG04BXZ059X001010102763","左卡尼汀口服溶液","口服溶液剂","10ml:1g","钠钙玻璃管制口服液体瓶","支","盒",10,"国药准字H20254530","石家庄四药有限公司","石家庄四药有限公司","是","否","新化药4类",79.8,"符合(视同通过一致性评价仿制药)","阳光目录","2025年第九批药品新增阳光挂网"]
["XS01BCP089G010010183191","普拉洛芬滴眼液","眼用制剂","0.1%(5ml:5mg)","聚丙烯药用滴眼剂瓶","支","盒",1,"国药准字H20254154","山东辰欣佛都药业股份有限公司","山东辰欣佛都药业股份有限公司","是","否","新化药4类",19.8,"符合(视同通过一致性评价仿制药)","阳光目录","2025年第九批药品新增阳光挂网"]
["XN06ABF071A001020180698","马来酸氟伏沙明片","片剂","100mg","聚氯乙烯/聚偏二氯乙烯固体药用复合硬片、药用铝箔包装","片","盒",30,"国药准字H20254152","合肥英太制药有限公司","合肥英太制药有限公司","是","否","新化药4类",102.96,"符合(视同通过一致性评价仿制药)","阳光目录","2025年第九批药品新增阳光挂网"]
["XR05CBX169X001010284160","盐酸溴己新口服溶液","口服溶液剂","100ml:0.2g","口服液体药用聚酯含热封垫片瓶,配备有带刻度的量杯。","瓶","盒",1,"国药准字H20254405","浙江赛默制药有限公司","海南康成药业有限公司","是","否","通过一致性评价",35.18,"符合(视同通过一致性评价仿制药)","阳光目录","2025年第九批药品新增阳光挂网"]
["XJ02ACA370B001010183093","注射用硫酸艾沙康唑","注射剂","0.2g(按C₂₂H₁₇F₂N₅OS计)","高硼硅玻璃管制注射剂瓶、注射用冷冻干燥无菌粉末用覆聚四氟乙烯/乙烯共聚物膜氯化丁基橡胶塞和抗生素瓶用铝塑组合盖包装","瓶","瓶",1,"国药准字H20254537","山西德元堂药业有限公司","山东力诺制药有限公司","是","否","新化药4类",965,"符合(视同通过一致性评价仿制药)","阳光目录","2025年第九批药品新增阳光挂网"]
["XD01AEA039T001010180651","盐酸阿莫罗芬搽剂","搽剂","5%(2.5ml:125mg,按C₂₁H₃₅NO计)","钠钙玻璃模制药瓶包装","瓶","盒",1,"国药准字H20254685","福元药业有限公司","福元药业有限公司","否","否","通过一致性评价",199.28,"符合(视同通过一致性评价仿制药)","阳光目录","2025年第九批药品新增阳光挂网"]
["XC02CAD177A010010102180","甲磺酸多沙唑嗪缓释片","薄膜衣片","4mg(按C₂₃H₂₅N₅O₅计)","聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片和药用铝箔。","片","盒",10,"国药准字H20253807","四川科伦药业股份有限公司","四川科伦药业股份有限公司","是","否","新化药4类",38.35,"符合(视同通过一致性评价仿制药)","阳光目录","2025年第九批药品新增阳光挂网"]
["XM03ACW026B001010104948","注射用维库溴铵","注射剂","10mg","中硼硅玻璃管制注射剂瓶、注射用冷冻干燥用覆乙烯-四氟乙烯共聚物膜氯化丁基橡胶塞包装。","瓶","瓶",1,"国药准字H20253997","湖南科伦制药有限公司","湖南科伦制药有限公司","是","否","新化药4类",10,"符合(视同通过一致性评价仿制药)","阳光目录","2025年第九批药品新增阳光挂网"]
["XR03ACF104L020010104948","富马酸福莫特罗吸入溶液","吸入制剂","2ml:20μg(按(C₁₉H₂₄N₂O₄)₂•C₄H₄O₄计)","内包装为聚乙烯安瓿,外包装为纸/铝/聚乙烯药品包装用复合袋。","支","盒",60,"国药准字H20254001","湖南科伦制药有限公司","湖南科伦制药有限公司","是","否","新化药3类",1110,"符合(视同通过一致性评价仿制药)","阳光目录","2025年第九批药品新增阳光挂网"]
["XR03ACF104L020010204948","富马酸福莫特罗吸入溶液","吸入制剂","2ml:20μg(按(C₁₉H₂₄N₂O₄)₂•C₄H₄O₄计)","内包装为聚乙烯安瓿,外包装为纸/铝/聚乙烯药品包装用复合袋。","支","盒",30,"国药准字H20254001","湖南科伦制药有限公司","湖南科伦制药有限公司","是","否","新化药3类",555,"符合(视同通过一致性评价仿制药)","阳光目录","2025年第九批药品新增阳光挂网"]
["XL04AAM033A012010284230","麦考酚钠肠溶片","片剂","0.18g(按C17H20O6计)","本品包装材料为药用铝箔和聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片","片","盒",50,"国药准字H20254003","华益药业科技(安徽)有限公司","浙江美迪深生物医药有限公司","是","否","通过一致性评价",290,"符合(视同通过一致性评价仿制药)","阳光目录","2025年第九批药品新增阳光挂网"]
["XA10BDE085A001010309665","二甲双胍恩格列净片(V)","片剂","每片含盐酸二甲双胍1000mg与恩格列净5mg","聚氯乙烯/聚偏二氯乙烯固体药用复合硬片和药用铝箔包装","片","盒",30,"国药准字H20254624","常州市阳光药业有限公司","常州市阳光药业有限公司","否","否","新化药4类",44.19,"符合(视同通过一致性评价仿制药)","阳光目录","2025年第九批药品新增阳光挂网","专家论证结果"]
["XA10BDE085A001010209665","二甲双胍恩格列净片(V)","片剂","每片含盐酸二甲双胍1000mg与恩格列净5mg","聚氯乙烯/聚偏二氯乙烯固体药用复合硬片和药用铝箔包装","片","盒",20,"国药准字H20254624","常州市阳光药业有限公司","常州市阳光药业有限公司","否","否","新化药4类",29.9,"符合(视同通过一致性评价仿制药)","阳光目录","2025年第九批药品新增阳光挂网","专家论证结果"]
["XD10ADA013U001010184410","阿达帕林凝胶","凝胶剂","0.1%(30g:30mg)","药用聚乙烯/铝/聚乙烯复合软膏管","支","盒",1,"国药准字H20249038","药源生物科技(启东)有限公司","苏州高迈药业有限公司","是","否","通过一致性评价",45,"符合(视同通过一致性评价仿制药)","阳光目录","2025年第九批药品新增阳光挂网"]
["XM01AEL283X001010284106","洛索洛芬钠口服溶液","口服溶液剂","10ml:60mg(按C₁₅H₁₇NaO₃计)","钠钙玻璃管制口服液体瓶、口服液用易刺型氯化丁基橡胶塞和口服液瓶用铝塑组合盖。","支","盒",6,"国药准字H20253798","湖南先施制药有限公司","湖南先施制药有限公司","否","否","通过一致性评价",59.76,"符合(视同通过一致性评价仿制药)","阳光目录","2025年第九批药品新增阳光挂网"]
["XM01AEL283X001010184106","洛索洛芬钠口服溶液","口服溶液剂","10ml:60mg(按C₁₅H₁₇NaO₃计)","钠钙玻璃管制口服液体瓶、口服液用易刺型氯化丁基橡胶塞和口服液瓶用铝塑组合盖。","支","盒",9,"国药准字H20253798","湖南先施制药有限公司","湖南先施制药有限公司","否","否","通过一致性评价",89.64,"符合(视同通过一致性评价仿制药)","阳光目录","2025年第九批药品新增阳光挂网"]
["XJ05AFE013X001010105765","恩替卡韦口服溶液","口服溶液剂","210ml:10.5mg","口服液体药用高密度聚乙烯瓶、儿童安全盖,附带聚乙烯口服给药器","瓶","盒",1,"国药准字H20244438","海南全星制药有限公司","海南全星制药有限公司","是","否","通过一致性评价",43.1,"符合(视同通过一致性评价仿制药)","阳光目录","2025年第九批药品新增阳光挂网"]
["XR03CCA199X001010105407","氨溴特罗口服溶液","口服溶液剂","100ml:盐酸氨溴索150mg与盐酸克仑特罗100µg","口服液体药用聚酯瓶和液体药用塑料瓶盖","瓶","盒",1,"国药准字H20249471","湖南九典制药股份有限公司","江西仁齐制药有限公司","否","否","新化药3类",29.8,"符合(视同通过一致性评价仿制药)","阳光目录","2025年第九批药品新增阳光挂网"]
["XA10BKD256A001010579426","达格列净片","片剂","5mg(按C₂₁H₂₅ClO₆计)","聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片/药用铝箔。","片","盒",10,"国药准字HJ20250029","Hetero Labs Limited","江西省华药医药有限公司","是","是","通过一致性评价",18.17,"符合(视同通过一致性评价仿制药)","阳光目录","2025年第九批药品新增阳光挂网"]
["XJ01XAT037B001010184294","注射用替考拉宁","注射剂","0.2g(20万单位)","中性硼硅玻璃管制注射剂瓶、注射用冷冻干燥用溴化丁基橡胶塞、抗生素瓶用铝塑组合盖包装","瓶","瓶",1,"国药准字H20253606","丹东医创药业有限责任公司","东阳祥昇医药科技有限公司","是","否","通过一致性评价",139,"符合(视同通过一致性评价仿制药)","阳光目录","2025年第九批药品新增阳光挂网"]
["XL01BCA062B001010182719","注射用阿糖胞苷","注射剂","0.1g","中性硼硅玻璃管制注射剂瓶、注射用冷冻干燥无菌粉末用卤化丁基橡胶塞(溴化)以及抗生素瓶用铝塑组合盖包装","支","盒",1,"国药准字H20254280","合肥亿帆生物制药有限公司","合肥亿帆生物制药有限公司","是","是","通过一致性评价",36,"符合(视同通过一致性评价仿制药)","阳光目录","2025年第九批药品新增阳光挂网"]
["XG03AAQ167A001010183802","屈螺酮炔雌醇片(II)","片剂(薄膜衣片)","屈螺酮3.000mg和炔雌醇0.020mg(24片含药片＋4片安慰片)","聚氯乙烯/聚三氟氯乙烯固体药用复合硬片和药用铝箔包装。","片","盒",28,"国药准字H20249192","南通联亚药业股份有限公司","南通联亚药业股份有限公司","否","否","新化药4类",118.72,"符合(视同通过一致性评价仿制药)","阳光目录","2025年第九批药品新增阳光挂网"]
["XM01ABC065A001010103184","醋氯芬酸片","片剂","0.1g","双层聚酯/铝/聚乙烯药用复合膜包装","片","盒",12,"国药准字H20253975","河南诺美药业有限公司","河南诺美药业有限公司","是","否","新化药3类",47.6,"符合(视同通过一致性评价仿制药)","阳光目录","2025年第九批药品新增阳光挂网"]
["XR05CBX169X001010180651","盐酸溴己新口服溶液","口服溶液剂","100ml:0.2g","钠钙玻璃模制药瓶,口服药用聚烯烃安全盖。配有带刻度的量杯。","瓶","盒",1,"国药准字H20254393","福元药业有限公司","福元药业有限公司","是","否","通过一致性评价",35.2,"符合(视同通过一致性评价仿制药)","阳光目录","2025年第九批药品新增阳光挂网"]
["XN05BAA217A001010302181","奥沙西泮片","片剂","15mg","聚三氟氯乙烯/聚氯乙烯固体药用复合硬片和药用铝箔。","片","盒",20,"国药准字H20254336","成都苑东生物制药股份有限公司","成都苑东生物制药股份有限公司","是","否","新化药3类",60.56,"符合(视同通过一致性评价仿制药)","阳光目录","2025年第九批药品新增阳光挂网"]
["XN05BAA217A001010202181","奥沙西泮片","片剂","15mg","聚三氟氯乙烯/聚氯乙烯固体药用复合硬片和药用铝箔。","片","盒",30,"国药准字H20254336","成都苑东生物制药股份有限公司","成都苑东生物制药股份有限公司","是","否","新化药3类",89.5,"符合(视同通过一致性评价仿制药)","阳光目录","2025年第九批药品新增阳光挂网"]
["XA12BAF601B002010183325","复合磷酸氢钾注射液","注射剂","5ml∶磷酸二氢钾1.12g和磷酸氢二钾(按K₂HPO₄计)1.18g","聚丙烯安瓿包装","支","支",1,"国药准字H20254092","山东华鲁制药有限公司","成都欣捷高新技术开发股份有限公司","是","否","新化药3类",49.6,"符合(视同通过一致性评价仿制药)","阳光目录","2025年第九批药品新增阳光挂网"]
["XR03CCB127N001010101522","盐酸丙卡特罗颗粒","颗粒剂","25μg(按C₁₆H₂₂N₂O₃·HCl·½H₂O计)","聚酯/铝/聚乙烯药用复合膜","袋","盒",10,"国药准字H20254102","江苏正大清江制药有限公司","江苏正大清江制药有限公司","是","否","新化药3类",97.49,"符合(视同通过一致性评价仿制药)","阳光目录","2025年第九批药品新增阳光挂网"]
["XA16AXL154A001010584211","硫辛酸片","片剂","0.6g","口服固体药用高密度聚乙烯瓶","片","瓶",7,"国药准字H20254560","浙江赛默制药有限公司","浙江百代医药科技有限公司","否","否","新化药3类",138.45,"符合(视同通过一致性评价仿制药)","阳光目录","2025年第九批药品新增阳光挂网"]
["XA16AXL154A001010184211","硫辛酸片","片剂","0.6g","口服固体药用高密度聚乙烯瓶","片","瓶",14,"国药准字H20254560","浙江赛默制药有限公司","浙江百代医药科技有限公司","否","否","新化药3类",269.97,"符合(视同通过一致性评价仿制药)","阳光目录","2025年第九批药品新增阳光挂网"]
["XC09DBT176A001010183916","替米沙坦氨氯地平片","片剂","每片含替米沙坦80mg与苯磺酸氨氯地平5mg(按C₂₀H₂₅ClN₂O₅计)","聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片和药用铝箔包装","片","盒",7,"国药准字H20254641","四川科伦药业股份有限公司","湖南慧泽生物医药科技有限公司","是","否","新化药4类",34.93,"符合(视同通过一致性评价仿制药)","阳光目录","2025年第九批药品新增阳光挂网"]
["XM05BAA029A001010185085","阿仑膦酸钠片","片剂","70mg(按C₄H₁₃NO₇P₂计)","聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片及药用铝箔包装","片","盒",2,"国药准字H20254214","安徽艾立德制药有限公司","安徽艾立德制药有限公司","是","是","新化药4类",25.3,"符合(视同通过一致性评价仿制药)","阳光目录","2025年第九批药品新增阳光挂网"]
["XN05ADF085A001010104658","氟哌啶醇片","片剂","2mg","口服固体药用高密度聚乙烯瓶","片","瓶",100,"国药准字H20254337","浙江京新药业股份有限公司","浙江京新药业股份有限公司","是","是","通过一致性评价",27.25,"符合(视同通过一致性评价仿制药)","阳光目录","2025年第九批药品新增阳光挂网"]
["XR06AEX017X001010183014","盐酸西替利嗪口服溶液","口服溶液剂","100ml∶0.1g","口服液体药用聚酯瓶,配有口服液体药用聚丙烯量杯。","瓶","盒",1,"国药准字H20254566","华益泰康药业股份有限公司","福建海西新药创制股份有限公司","是","否","新化药3类",31.88,"符合(视同通过一致性评价仿制药)","阳光目录","2025年第九批药品新增阳光挂网"]
["XL04AXB245E001020101749","泊马度胺胶囊","胶囊剂","1mg","口服固体药用高密度聚乙烯瓶","粒","盒",21,"国药准字H20253721","扬子江药业集团有限公司","扬子江药业集团有限公司","是","否","通过一致性评价",1350,"符合(视同通过一致性评价仿制药)","阳光目录","2025年第九批药品新增阳光挂网"]
["XL04AXB245E001010101749","泊马度胺胶囊","胶囊剂","4mg","口服固体药用高密度聚乙烯瓶","粒","盒",21,"国药准字H20253720","扬子江药业集团有限公司","扬子江药业集团有限公司","是","否","通过一致性评价",3901.5,"符合(视同通过一致性评价仿制药)","阳光目录","2025年第九批药品新增阳光挂网"]
["XC10AXU011E002010101749","ω-3脂肪酸乙酯90软胶囊","胶囊剂","1g(每粒胶囊含二十碳五烯酸乙酯465mg,二十二碳六烯酸乙酯375mg,ω-3脂肪酸乙酯总量不低于900mg)","口服固体药用高密度聚乙烯瓶","粒","盒",28,"国药准字H20249504","扬子江药业集团有限公司","扬子江药业集团有限公司","否","否","通过一致性评价",224,"符合(视同通过一致性评价仿制药)","阳光目录","2025年第九批药品新增阳光挂网"]
["XN01AXY337B002010101749","依托咪酯中/长链脂肪乳注射液","注射剂","10ml:20mg","中硼硅玻璃安瓿","支","支",1,"国药准字H20249023","扬子江药业集团有限公司","扬子江药业集团有限公司","是","否","通过一致性评价",33.6,"符合(视同通过一致性评价仿制药)","阳光目录","2025年第九批药品新增阳光挂网"]
["XJ02ACA370B001010104187","注射用硫酸艾沙康唑","注射剂","0.2g(按C₂₂H₁₇F₂N₅OS计)","高硼硅玻璃管制注射剂瓶、冷冻干燥注射用局部覆聚四氟乙烯膜卤化丁基橡胶塞(溴化)、抗生素瓶用铝塑组合盖包装。","瓶","盒",1,"国药准字H20254347","山西普德药业有限公司","山东新华制药股份有限公司","是","否","新化药4类",965,"符合(视同通过一致性评价仿制药)","阳光目录","2025年第九批药品新增阳光挂网"]
["XD06AXF045F002010184221","夫西地酸乳膏","乳膏剂","2%(15g:0.3g,按C₃₁H₄₈O₆计)","铝质药用软膏管包装","支","盒",2,"国药准字H20254526","浙江赛默制药有限公司","浙江高跖医药科技股份有限公司","是","否","通过一致性评价",40.47,"符合(视同通过一致性评价仿制药)","阳光目录","2025年第九批药品新增阳光挂网"]
["XC04AEN041A001020204647","尼麦角林片","片剂","10mg","聚氯乙烯固体药用硬片和药用铝箔包装,外套聚酯/铝/聚乙烯药用复合膜袋,内置固体药用纸袋装硅胶干燥剂","片","盒",30,"国药准字H20254671","浙江华海药业股份有限公司","浙江华海药业股份有限公司","是","否","新化药3类",27,"符合(视同通过一致性评价仿制药)","阳光目录","2025年第九批药品新增阳光挂网"]
["XN02CCF749A001010204036","琥珀酸呋罗曲坦片","片剂(薄膜衣片)","2.5mg(按C₁₄H₁₇N₃O 计)","铝塑包装(药用铝箔＋聚氯乙烯固体药用硬片),外套聚酯/铝/聚乙烯药用复合膜袋。","片","盒",4,"国药准字H20244535","青岛国信制药有限公司","青岛国信制药有限公司","否","否","通过一致性评价",470.76,"符合(视同通过一致性评价仿制药)","阳光目录","2025年第九批药品新增阳光挂网"]
["XJ05ABF003A001020101751","盐酸伐昔洛韦片","片剂(薄膜衣片)","0.5g(按C₁₃H₂₀N₆O₄计)","聚氯乙烯/聚偏二氯乙烯固体药用复合硬片及药用铝箔","片","盒",10,"国药准字H20258039","德全药品(江苏)股份有限公司","德全药品(江苏)股份有限公司","是","否","通过一致性评价",149.5,"符合(视同通过一致性评价仿制药)","阳光目录","2025年第九批药品新增阳光挂网"]
["XC01BDJ205A001010104021","盐酸决奈达隆片","片剂","400mg(按C₃₁H₄₄N₂O₅S计)","聚氯乙烯固体药用硬片和药用铝箔","片","盒",20,"国药准字H20254815","齐鲁制药有限公司","齐鲁制药有限公司","否","否","新化药4类",196,"符合(视同通过一致性评价仿制药)","阳光目录","2025年第九批药品新增阳光挂网"]
["XC10AXE095E002010204021","二十碳五烯酸乙酯软胶囊","胶囊剂","1.0g","口服固体药用高密度聚乙烯瓶","粒","盒",120,"国药准字H20254765","齐鲁制药有限公司","齐鲁制药有限公司","否","否","新化药4类",882,"符合(视同通过一致性评价仿制药)","阳光目录","2025年第九批药品新增阳光挂网"]
["XA10BKD256A001020679426","达格列净片","片剂","10mg(按C₂₁H₂₅ClO₆计)","聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片/药用铝箔。","片","盒",30,"国药准字HJ20250030","Hetero Labs Limited","江西省华药医药有限公司","是","是","新化药5.2类",89.01,"符合(视同通过一致性评价仿制药)","阳光目录","2025年第九批药品新增阳光挂网"]
["XR03CCB127X001010183033","盐酸丙卡特罗口服溶液","口服溶液剂","100ml:0.5mg","口服液体药用聚酯瓶装;附带量杯","瓶","盒",1,"国药准字H20254528","河北仁合益康药业有限公司","仁合益康集团有限公司","是","否","新化药3类",31.23,"符合(视同通过一致性评价仿制药)","阳光目录","2025年第九批药品新增阳光挂网"]
["XS01EAX225G010010102733","溴莫尼定噻吗洛尔滴眼液","眼用制剂","5ml:酒石酸溴莫尼定10.0mg和马来酸噻吗洛尔25.0mg(按C₁₃H₂₄N₄O₃S计)","低密度聚乙烯药用滴眼剂瓶","支","盒",1,"国药准字H20254074","石家庄格瑞药业有限公司","石家庄格瑞药业有限公司","否","否","新化药4类",99.78,"符合(视同通过一致性评价仿制药)","阳光目录","2025年第九批药品新增阳光挂网"]
["XA16AAX051B001010104685","注射用丁二磺酸腺苷蛋氨酸","注射剂","0.5g(以腺苷蛋氨酸计)","粉针:中硼硅玻璃管制注射剂瓶、注射用冷冻干燥用氯化丁基橡胶塞、抗生素瓶用铝塑组合盖。注射用溶剂:中硼硅玻璃安瓿","支","支",1,"国药准字H20249311","浙江普洛康裕制药有限公司","浙江普洛康裕制药有限公司","是","否","新化药4类",26.5,"符合(视同通过一致性评价仿制药)","阳光目录","2025年第九批药品新增阳光挂网"]
["XM03BAM059B002010101478","美索巴莫注射液","注射液","10ml:1g","中硼硅玻璃安瓿","支","支",1,"国药准字H20254366","江苏神龙药业有限公司","江苏神龙药业有限公司","否","否","新化药3类",98.8,"符合(视同通过一致性评价仿制药)","阳光目录","2025年第九批药品新增阳光挂网"]
["XN02ADY086B002010182719","氢溴酸依他佐辛注射液","注射剂","1ml:15mg(按C₁₅H₂₁NO计)","中硼硅玻璃安瓿","支","支",1,"国药准字H20253797","合肥亿帆生物制药有限公司","合肥亿帆生物制药有限公司","否","否","通过一致性评价",279,"符合(视同通过一致性评价仿制药)","阳光目录","2025年第九批药品新增阳光挂网"]
["XN04BAD164A001010101003","多巴丝肼片","片剂","左旋多巴0.2g与苄丝肼50mg(相当于盐酸苄丝肼57mg)","口服固体药用高密度聚乙烯瓶、固体药用纸袋装硅胶干燥剂及固体药用塑料瓶盖(含垫片)包装","片","瓶",40,"国药准字H20254401","重庆华邦制药有限公司","重庆华邦制药有限公司","是","是","新化药4类",68.9,"符合(视同通过一致性评价仿制药)","阳光目录","2025年第九批药品新增阳光挂网"]
["XC08CAN038B002010204647","盐酸尼卡地平注射液","注射剂","10ml:10mg","中硼硅玻璃安瓿(棕色)","支","支",1,"国药准字H20254793","浙江华海药业股份有限公司","浙江华海药业股份有限公司","是","否","新化药4类",42.7,"符合(视同通过一致性评价仿制药)","阳光目录","2025年第九批药品新增阳光挂网"]
["XN06ABF071A001010380698","马来酸氟伏沙明片","片剂","50mg","聚氯乙烯/聚偏二氯乙烯固体药用复合硬片、药用铝箔包装","片","盒",30,"国药准字H20254151","合肥英太制药有限公司","合肥英太制药有限公司","是","否","新化药4类",60.57,"符合(视同通过一致性评价仿制药)","阳光目录","2025年第九批药品新增阳光挂网"]
["XN02BED158N001010102763","对乙酰氨基酚颗粒","颗粒剂","0.1g","聚酯/铝/聚乙烯药用复合膜、袋包装","袋","盒",6,"国药准字H20254709","石家庄四药有限公司","石家庄四药有限公司","是","是","新化药3类",46.2,"符合(视同通过一致性评价仿制药)","阳光目录","2025年第九批药品新增阳光挂网"]
["XA10BDS251A010010101605","沙格列汀二甲双胍缓释片(Ⅰ)","片剂","每片含沙格列汀5mg和盐酸二甲双胍1000mg","口服固体药用高密度聚乙烯瓶","片","盒",14,"国药准字H20254230","南京易亨制药有限公司","南京易亨制药有限公司","是","否","新化药4类",95.15,"符合(视同通过一致性评价仿制药)","阳光目录","2025年第九批药品新增阳光挂网"]
["XC09BBP131A001010183830","培哚普利氨氯地平片(Ⅲ)","片剂","每片含精氨酸培哚普利10mg、苯磺酸氨氯地平5mg(按C₂₀H₂₅N₂O₅Cl计)","口服固体药用高密度聚乙烯瓶和口服固体药用低密度聚乙烯防潮组合瓶盖","片","瓶",10,"国药准字H20254925","成都硕德药业有限公司","成都硕德药业有限公司","是","否","新化药4类",41.3,"符合(视同通过一致性评价仿制药)","阳光目录","2025年第九批药品新增阳光挂网"]
["XN06AXA268A001010183603","阿戈美拉汀片","片剂(薄膜衣片)","25mg","药用铝箔和聚氯乙烯固体药用硬片","片","盒",14,"国药准字H20253920","石家庄龙泽制药股份有限公司","北京海步医药科技有限公司","是","否","新化药4类",119,"符合(视同通过一致性评价仿制药)","阳光目录","2025年第九批药品新增阳光挂网"]
["XC07ABM062B002010101723","酒石酸美托洛尔注射液","注射剂","5ml:酒石酸美托洛尔5mg与氯化钠45mg","中硼硅玻璃安瓿","支","支",1,"国药准字H20055270","江苏朗欧药业有限公司","江苏朗欧药业有限公司","是","是","通过一致性评价",39.6,"符合(视同通过一致性评价仿制药)","阳光目录","2025年第九批药品新增阳光挂网"]
["XJ02ACA370B001010102690","注射用硫酸艾沙康唑","注射剂","0.2g(按C₂₂H₁₇F₂N₅OS计)","高硼硅玻璃管制注射剂瓶、冷冻干燥注射用局部覆聚四氟乙烯膜卤化丁基橡胶塞(溴化)和抗生素瓶用铝塑组合盖包装","瓶","盒",1,"国药准字H20254299","华北制药股份有限公司","华北制药股份有限公司","是","否","新化药4类",996,"符合(视同通过一致性评价仿制药)","阳光目录","2025年第九批药品新增阳光挂网"]
["XM02AAS197U002010284221","双氯芬酸二乙胺乳胶剂","凝胶剂","1%(20g:0.2g,按C₁₄H₁₀Cl₂NNaO₂计)","铝质药用软膏管包装","支","盒",2,"国药准字H20254434","浙江赛默制药有限公司","浙江高跖医药科技股份有限公司","是","否","通过一致性评价",34.3,"符合(视同通过一致性评价仿制药)","阳光目录","2025年第九批药品新增阳光挂网"]
["XM02AAS197U002010184221","双氯芬酸二乙胺乳胶剂","凝胶剂","1%(20g:0.2g,按C₁₄H₁₀Cl₂NNaO₂计)","铝质药用软膏管包装","支","盒",3,"国药准字H20254434","浙江赛默制药有限公司","浙江高跖医药科技股份有限公司","是","否","通过一致性评价",51.45,"符合(视同通过一致性评价仿制药)","阳光目录","2025年第九批药品新增阳光挂网"]
["XS01BCX230G010010284784","溴芬酸钠滴眼液","眼用制剂","0.1%(5ml:5mg,按C₁₅H₁₁BrNNaO₃•1½H₂O计)","低密度聚乙烯药用滴眼剂瓶","瓶","盒",1,"国药准字H20244161","润尔眼科药物(广州)有限公司","润尔眼科药物(广州)有限公司","是","否","新化药4类",42,"符合(视同通过一致性评价仿制药)","阳光目录","2025年第九批药品新增阳光挂网"]
["XC01DXN039A001010183273","尼可地尔片","片剂","5mg","聚氯乙烯固体药用硬片和药用铝箔,聚酯/铝/聚乙烯药用复合膜、袋(内放固体药用纸袋装干燥剂1袋)","片","盒",30,"国药准字H20249805","扬州市三药制药有限公司","北京沃邦医药科技有限公司","是","是","新化药4类",28.1,"符合(视同通过一致性评价仿制药)","阳光目录","2025年第九批药品新增阳光挂网"]
["XJ01DHB274B002010104948","注射用比阿培南/氯化钠注射液","注射剂","粉体室:0.3g(按C₁₅H₁₈N₄O₄S计);液体室100ml:氯化钠0.9g","三层共挤(粉-液)输液用袋包装","袋","袋",1,"国药准字H20254124","湖南科伦制药有限公司","湖南科伦制药有限公司","否","否","新化药3类",65,"符合(视同通过一致性评价仿制药)","阳光目录","2025年第九批药品新增阳光挂网","专家论证结果"]
["XB01ACY170A001010502877","吲哚布芬片","片剂","0.2g","聚氯乙烯固体药用硬片和药用铝箔包装","片","盒","7","国药准字H20253852","山西德元堂药业有限公司","山西德元堂药业有限公司","是","否","过评仿制药(含视同)",78.66,"符合(视同通过一致性评价仿制药)","阳光目录","2025年第九批药品新增阳光挂网"]
["XC09DBT195A001010102877","替米沙坦氨氯地平片(Ⅱ)","片剂","每片含替米沙坦40mg与苯磺酸氨氯地平5mg(以氨氯地平计)","药用铝箔、聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片包装","片","盒","7","国药准字H20253314","山西德元堂药业有限公司","山西德元堂药业有限公司","否","否","过评仿制药(含视同)",41.86,"符合(视同通过一致性评价仿制药)","阳光目录","2025年第九批药品新增阳光挂网"]
["XS01EET161G010010101749","他氟前列素滴眼液","眼用制剂","0.0015%(0.3ml:4.5μg)","低密度聚乙烯药用滴眼剂瓶","支","盒",24,"国药准字H20243690","扬子江药业集团有限公司","扬子江药业集团有限公司","是","否","通过一致性评价",331.2,"符合(视同通过一致性评价仿制药)","阳光目录","2025年第九批药品新增阳光挂网"]
["XN05CFZ077A001020303372","佐匹克隆片","薄膜衣片","7.5mg","药品包装用铝箔/药用PVC硬片","片","盒",12,"国药准字H19991411","吉林金恒制药股份有限公司","吉林金恒制药股份有限公司","是","是","通过一致性评价",21.24,"符合(视同通过一致性评价仿制药)","阳光目录","2025年第九批药品新增阳光挂网"]
["XV01AAC028X002010179366","肠内营养混悬液(TPF-D)","口服混悬剂","500ml(1.01kcal/ml)","RTH塑料瓶","瓶","瓶",1,"国药准字HJ20160135","ABBOTT LABORATORIES B.V.","广州医药股份有限公司","是","否","原研药",82.17,"符合（不同作用释放时间）","阳光目录","2025年第九批药品新增阳光挂网"]
["XN02BEA253A001010100269","氨酚伪麻那敏片(Ⅰ)","片剂","每片含对乙酰氨基酚500mg,盐酸伪麻黄碱30mg,马来酸氯苯那敏2mg","药品包装用复合膜","片","盒",10,"国药准字H44024891","广东彼迪药业有限公司","广东彼迪药业有限公司","否","否","其他",6.34,"符合（不同作用释放时间）","阳光目录","2025年第九批药品新增阳光挂网","专家论证结果"]
["XL01XXT233A001010185407","氢溴酸他泽司他片","片剂(薄膜衣片)","200mg(按C₃₄H₄₄N₄O₄计)","高密度聚乙烯瓶及聚丙烯儿童安全盖包装,内置口服固体药用高密度聚乙烯柱状干燥剂","片","瓶",240,"国药准字HJ20250031","Patheon Pharmaceuticals Inc.","和记黄埔医药（上海）有限公司","否","否","原研药",32260,"符合（创新药）","阳光目录","2025年第九批药品新增阳光挂网"]
["XH02ABF752X002010185385","伐莫洛龙口服混悬液","口服混悬剂","100ml:4g","琥珀色玻璃瓶,瓶盖为聚丙烯防儿童开启安全盖,配有低密度聚乙烯衬垫。每个包装内含1瓶药液、1个压入式瓶适配器(低密度聚乙烯材质)以及2个相同的口服给药器(低密度聚乙烯材质),给药器的刻度范围为0至8ml","瓶","盒",1,"国药准字HJ20240165","Purna Pharmaceuticals NV/SA","上药国际供应链有限公司","否","否","其他",22480,"符合（创新药）","阳光目录","2025年第九批药品新增阳光挂网"]
["XL04ACF759B001010103315","注射用伏欣奇拜单抗","注射剂","200mg/瓶","直接接触药品的包装材料:中硼硅玻璃管制注射剂瓶、冷冻干燥用溴化丁基橡胶塞。1瓶/盒,内附1枚与注射用伏欣奇拜单抗配套使用的一次性使用药液转移器。","瓶","盒",1,"国药准字S20250036","长春金赛药业有限责任公司","长春金赛药业有限责任公司","否","否","生物制剂创新药",8988,"符合（创新药）","阳光目录","2025年第九批药品新增阳光挂网"]
["XL01EBZ115A001020183861","盐酸佐利替尼片","片剂","50mg(按C₂₂H₂₃ClFN₅O₃计)","本品采用口服固体药用高密度聚乙烯瓶、口服固体药用聚丙烯/低密度聚乙烯儿童安全防潮组合瓶盖包装,内含口服固体药用高密度聚乙烯干燥剂罐。","片","瓶",28,"国药准字H20240039","江苏晨泰医药科技有限公司","江苏晨泰医药科技有限公司","否","否","原研药",2876,"符合（创新药）","阳光目录","2025年第九批药品新增阳光挂网"]
["XL04AGA422B002010181735","奥瑞利珠单抗注射液","注射剂","300mg(10ml)/瓶","西林瓶","瓶","盒",1,"国药准字SJ20250013","ROCHE DIAGNOSTICS GMBH","罗氏（上海）医药贸易有限公司","否","否","原研药",40000,"符合（创新药）","阳光目录","2025年第九批药品新增阳光挂网"]
["XJ05APA421A001010180955","艾考磷布韦片","薄膜衣片","0.3g","聚氯乙烯固体药用硬片和药用铝箔包装","片","盒",28,"国药准字H20250010","宜昌东阳光长江药业股份有限公司","宜昌东阳光长江药业股份有限公司","否","否","原研药",2000,"符合（创新药）","阳光目录","2025年第九批药品新增阳光挂网","专家论证结果"]
["XJ05APN134E001010106988","磷酸萘坦司韦胶囊","胶囊剂","0.1g(按C₅₁H₅₈N₈O₇计)","聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片、药用铝箔","粒","盒",28,"国药准字H20250007","宜昌东阳光长江药业股份有限公司","广东东阳光药业股份有限公司","否","否","原研药",2000,"符合（创新药）","阳光目录","2025年第九批药品新增阳光挂网","专家论证结果"]
["XL04ACY366B002010182957","依若奇单抗注射液","注射剂","预灌封注射器:135mg(1mL)/支","本品直接接触药品的包材为:预灌封注射器组合件(带注射针)、预灌封注射器用溴化丁基橡胶活塞","支","盒",1,"国药准字S20250017","康融东方(广东)医药有限公司","中山康方生物医药有限公司","否","否","生物制剂创新药",9900,"符合（创新药）","阳光目录","2025年第九批药品新增阳光挂网","专家论证结果"]
["XN05CJL438A001020179086","莱博雷生片","片剂","5mg","聚氯乙烯固体药用硬片和药用铝箔。","片","盒",28,"国药准字HJ20250058","EISAI MANUFACTURING LIMITED","上药控股有限公司","否","否","参比制剂",498,"符合（创新药）","阳光目录","2025年第九批药品新增阳光挂网"]
["XL02BBD378E002010184539","氘恩扎鲁胺软胶囊","胶囊剂","40mg","聚三氟氯乙烯/聚氯乙烯固体药用复合硬片和药用铝箔制成的泡罩包装;外套聚酯/铝/聚乙烯药用复合袋。","粒","盒",28,"国药准字H20250029","人福普克药业(武汉)有限公司","海创药业股份有限公司","否","否","原研药",6500,"符合（创新药）","阳光目录","2025年第九批药品新增阳光挂网"]
["XL01XXR117B002010182966","瑞基奥仑赛注射液","注射剂","每支体积约为5ml,含不低于25*10^6CAR-T细胞","本品装于环烯烃共聚物(COC)的5ml冻存管内；冻存管放置在有内衬卡槽的纸盒中；运输用保温箱的隔热层材质为EPS,蓄冷剂为干冰","支","盒",1,"国药准字S20210035","苏州药明巨诺生物科技有限公司","上海药明巨诺生物科技有限公司","否","否","其他",1290000,"符合（独家品种）","阳光目录","2025年第九批药品新增阳光挂网","专家论证结果"]
["ZA09CAB0413010302039","补肾固齿丸","薄膜衣水丸","4g/袋(每30丸重1g)","药用复合膜","袋","盒",9,"国药准字Z51021248","成都九芝堂金鼎药业有限公司","成都九芝堂金鼎药业有限公司","是","否","其他",48.82,"符合（独家品种）","阳光目录","2025年第九批药品新增阳光挂网"]
["XL03ABL425B002010185332","罗培干扰素α-2b注射液","注射剂","预填充式注射器装：500μg(1ml)/支","预填充式注射器","支","盒",1,"国药准字SC20240001","药华医药股份有限公司台中分公司","中诺凯琳健康产业（海南）有限公司","否","否","其他",22250,"符合（独家品种）","阳光目录","2025年第九批药品新增阳光挂网"]
["ZG03AAJ0105010100083","健骨生丸","水丸","4.5g","纸盒","袋","盒",9,"国药准字Z10970030","北京匡达制药厂","北京匡达制药厂","否","否","其他",489.99,"符合（独家品种）","阳光目录","2025年第九批药品新增阳光挂网"]
["XB03AAF462X001010102062","复方三维亚铁口服溶液","口服溶液剂","复方,100ml","聚酯塑料药用包装瓶","瓶","盒",1,"国药准字H51023375","成都长青制药有限公司","成都长青制药有限公司","否","否","其他",62,"符合（独家品种）","阳光目录","2025年第九批药品新增阳光挂网"]
["ZA06EAP0047010104482","平喘益气颗粒","颗粒剂","每袋装3g(相当于饮片14.445g)","铝塑复合袋","袋","盒",6,"国药准字Z20050258","浙江康润制药有限公司","浙江康润制药有限公司","否","否","其他",43.69,"符合（独家品种）","阳光目录","2025年第九批药品新增阳光挂网"]
["ZA06BBB0495010178441","标准桃金娘油肠溶胶囊(儿童装)","胶囊剂(肠溶)","每粒装0.240g(含120mg标准桃金娘油)","PVC/PVDC铝箔泡罩包装","粒","盒",10,"国药准字ZJ20100007","G. Pohl-Boskamp GmbH & Co. KG","国药控股分销中心有限公司","是","否","其他",36,"符合（独家品种）","阳光目录","2025年第九批药品新增阳光挂网","专家论证结果"]
["ZB01DAJ0272010305295","结石通胶囊","胶囊剂","0.35g","无","粒","盒",48,"国药准字Z20060024","江西红星药业有限公司","江西红星药业有限公司","是","否","其他",38.9,"符合（独家申报）","阳光目录","2025年第九批药品新增阳光挂网"]
["ZC02AAY0277010100960","益肺清化膏","煎膏剂(膏滋)","每瓶装120g","药用塑料瓶包装","瓶","盒",2,"国药准字Z10950073","津药达仁堂集团股份有限公司达仁堂制药厂","津药达仁堂集团股份有限公司达仁堂制药厂","是","否","其他",680,"符合（独家申报）","阳光目录","2025年第九批药品新增阳光挂网"]
["XC01DXM021L001010103633","吗多明气雾剂","气雾剂","1%,每瓶重量14g,内含吗多明140mg","无","瓶","瓶",1,"国药准字H23022579","黑龙江省福乐康药业有限公司","黑龙江省福乐康药业有限公司","否","否","其他",141.67,"符合（独家申报）","阳光目录","2025年第九批药品新增阳光挂网"]
["ZA06CAZ0187010200326","止咳枇杷颗粒","颗粒剂","每袋重10g","药品包装用复合膜包装","袋","盒",10,"国药准字Z44021029","广东新峰药业股份有限公司","广东新峰药业股份有限公司","否","否","其他",25,"符合（独家申报）","阳光目录","2025年第九批药品新增阳光挂网"]
["ZA13BAZ0531010504586","左金胶囊","胶囊剂","每粒装0.35克","铝塑板装","粒","盒",9,"国药准字Z10980125","温州海鹤药业有限公司","温州海鹤药业有限公司","是","否","其他",46.15,"符合（独家申报）","阳光目录","2025年第九批药品新增阳光挂网"]
["ZA10CAA0074010102118","安乐胶囊","胶囊剂","每粒装0.4g","聚氯乙烯固体药用硬片/药用铝箔","粒","盒",24,"国药准字Z20090488","成都利尔药业有限公司","成都利尔药业有限公司","否","否","其他",38,"符合（独家申报）","阳光目录","2025年第九批药品新增阳光挂网"]
["ZI01AAP0004010105750","帕朱丸","丸剂","每丸重0.5g","铝塑泡罩","丸","盒",48,"国药准字Z20023297","西藏雄巴拉曲神水藏药有限公司","西藏雄巴拉曲神水藏药有限公司","是","否","其他",80,"符合（独家申报）","阳光目录","2025年第九批药品新增阳光挂网"]
["ZA17AAC0405010102058","除脂生发胶囊","胶囊剂(硬胶囊)","每粒装0.33g","药用PVC硬片/药品包装用PTP铝箔","粒","盒",120,"国药准字Z20090534","四川森科制药有限公司","四川森科制药有限公司","否","否","其他",77.99,"符合（独家申报）","阳光目录","2025年第九批药品新增阳光挂网"]
["XD02AXG038S004010104711","甘油外用溶液","溶液剂","80ml/瓶","塑料瓶","瓶","盒",1,"国药准字H20074202","浙江遂昌惠康药业有限公司","浙江遂昌惠康药业有限公司","否","否","其他",29.8,"符合（独家申报）","阳光目录","2025年第九批药品新增阳光挂网"]
["XR05XXF275K001010102062","复方甘草氯化铵糖浆","糖浆剂","复方(100ml/瓶)","口服液体药用塑料瓶","瓶","盒",1,"国药准字H51023320","成都长青制药有限公司","成都长青制药有限公司","否","否","其他",39.8,"符合（独家申报）","阳光目录","2025年第九批药品新增阳光挂网"]
["ZA14AAB0235020100798","保儿宁糖浆","糖浆剂","每瓶装120毫升(每毫升相当于生药1g)","口服液体药用聚酯瓶装","瓶","盒",1,"国药准字Z31020103","上海信仁中药制药有限公司","上海信仁中药制药有限公司","否","否","其他",68,"符合（儿科专科用药）","阳光目录","2025年第九批药品新增阳光挂网"]
["XN02BEX085N001010100269","小儿氨酚黄那敏颗粒","颗粒剂","对乙酰氨基酚125mg,马来酸氯苯那敏0.5mg,人工牛黄5mg","铝塑复合袋","袋","盒",10,"国药准字H44024486","广东彼迪药业有限公司","广东彼迪药业有限公司","否","否","其他",6.6,"符合（儿科专科用药）","阳光目录","2025年第九批药品新增阳光挂网"]
["XC10BAR128A001010202763","瑞舒伐他汀依折麦布片(I)","片剂","每片含瑞舒伐他汀钙10mg(按C₂₂H₂₈FN₃O₆S​计)与依折麦布10mg","聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片/药用铝箔","片","盒",10,"国药准字H20254910","石家庄四药有限公司","石家庄四药有限公司","是","否","新化药4类",21.7,"符合（国谈）集采","集采目录","2025年第九批药品新增阳光挂网"]
["XC10BAR128A001010102763","瑞舒伐他汀依折麦布片(I)","片剂","每片含瑞舒伐他汀钙10mg(按C₂₂H₂₈FN₃O₆S​计)与依折麦布10mg","聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片/药用铝箔","片","盒",30,"国药准字H20254910","石家庄四药有限公司","石家庄四药有限公司","是","否","新化药4类",65.1,"符合（国谈）集采","集采目录","2025年第九批药品新增阳光挂网"]
["XR05CBA198L019010183547","吸入用盐酸氨溴索溶液","吸入制剂","2ml:15mg","中硼硅玻璃安瓿","支","支",1,"国药准字H20254424","山西国润制药有限公司","山西阳和医药技术有限公司","是","否","通过一致性评价",8.44,"符合（国谈）集采","集采目录","2025年第九批药品新增阳光挂网"]
["XA06ADF336P001010183356","复方聚乙二醇(3350)电解质散","散剂","6.9g/袋","纸/铝/聚乙烯药品包装用复合膜","袋","盒",10,"国药准字H20255005","南京厚生药业有限公司","翎耀生物科技(上海)有限公司","是","是","新化药4类",36.9,"符合（国谈）集采","集采目录","2025年第九批药品新增阳光挂网"]
["XC10BAR128A001013283521","瑞舒伐他汀依折麦布片(I)","片剂","每片含瑞舒伐他汀钙10mg(按C₂₂H₂₈FN₃O₆S计)与依折麦布10mg","聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片和药用铝箔","片","盒",14,"国药准字H20254797","浙江诺得药业有限公司","浙江诺得药业有限公司","是","否","新化药4类",30.38,"符合（国谈）集采","集采目录","2025年第九批药品新增阳光挂网"]
["XJ01DDT188B001010183011","注射用头孢他啶阿维巴坦钠","注射剂","2.5g(C₂₂H₂₂N₆O₇S₂2.0g与C₇H₁₁N₃O₆S0.5g)","中硼硅模制注射剂瓶、注射用无菌粉末用局部覆聚四氟乙烯膜氯化丁基橡胶塞和抗生素瓶用铝塑组合盖包装","瓶","瓶",1,"国药准字H20243954","海口市制药厂有限公司,国药集团致君(深圳)制药有限公司","国药集团致君(深圳)制药有限公司","是","否","新化药4类",260,"符合（国谈）集采","集采目录","2025年第九批药品新增阳光挂网"]
["XA06ADF336P001010105819","复方聚乙二醇(3350)电解质散","散剂","6.9g/袋","聚酯/铝/聚乙烯药用复合膜、袋","袋","盒",10,"国药准字H20254388","华益泰康药业股份有限公司","华益泰康药业股份有限公司","是","否","新化药3类",36.5,"符合（国谈）集采","集采目录","2025年第九批药品新增阳光挂网"]
["XC10ABF728E003010104942","非诺贝特酸胆碱缓释胶囊","缓释胶囊","135mg(按C₁₇H₁₅ClO₄计)","聚氯⼄烯固体药⽤硬⽚、药⽤铝箔,双向拉伸聚酯/铝箔/聚⼄烯药品包装⽤复合膜和固体药⽤纸袋装硅胶⼲燥剂包装。","粒","盒",12,"国药准字H20254583","湖南九典制药股份有限公司","湖南九典制药股份有限公司","是","否","通过一致性评价",36.96,"符合（国谈）集采","集采目录","2025年第九批药品新增阳光挂网"]
["XR06AAB058A001020204420","盐酸苯海拉明片","片剂(薄膜衣片)","25mg(按C₁₇H₂₁NO·HCl计)","聚氯乙烯固体药用硬片/药品包装用铝箔,外套聚酯/铝/聚乙烯药品包装用复合膜袋","片","盒",30,"国药准字H34021399","黄山中皇制药有限公司","合肥创新医药技术有限公司","是","是","通过一致性评价",66.3,"符合（通过一致性评价仿制药）","阳光目录","2025年第九批药品新增阳光挂网"]
["XM03BXT046A001010301510","盐酸替扎尼定片","片剂","1mg(按C₉H₈ClN₅S计)","铝塑包装","片","盒",48,"国药准字H20041750","江苏亚邦爱普森药业有限公司","江苏亚邦爱普森药业有限公司","是","否","通过一致性评价",59.81,"符合（通过一致性评价仿制药）","阳光目录","2025年第九批药品新增阳光挂网"]
["XN06AXA268A001010185085","阿戈美拉汀片","片剂","25mg","铝箔泡罩","片","盒",14,"国药准字H20253818","安徽艾立德制药有限公司","安徽艾立德制药有限公司","是","否","新化药4类",133.84,"符合（通过一致性评价仿制药）","阳光目录","2025年第九批药品新增阳光挂网"]
["XA16AXL154A001020184106","硫辛酸片","片剂(薄膜衣片)","0.6g","铝塑泡罩","片","盒",3,"国药准字H20253712","浙江赛默制药有限公司","湖南先施制药有限公司","否","否","通过一致性评价",61.2,"符合（通过一致性评价仿制药）","阳光目录","2025年第九批药品新增阳光挂网"]
["XA16AXL154A001010384106","硫辛酸片","片剂(薄膜衣片)","0.2g","铝塑泡罩","片","盒",6,"国药准字H20253713","浙江赛默制药有限公司","湖南先施制药有限公司","否","否","通过一致性评价",52.8,"符合（通过一致性评价仿制药）","阳光目录","2025年第九批药品新增阳光挂网"]
["XA16AXL154A001010284106","硫辛酸片","片剂(薄膜衣片)","0.2g","铝塑泡罩","片","盒",12,"国药准字H20253713","浙江赛默制药有限公司","湖南先施制药有限公司","否","否","通过一致性评价",102.96,"符合（通过一致性评价仿制药）","阳光目录","2025年第九批药品新增阳光挂网"]
["XA16AXL154A001010184106","硫辛酸片","片剂(薄膜衣片)","0.2g","口服固体药用聚酯含热封垫片瓶","片","瓶",60,"国药准字H20253713","浙江赛默制药有限公司","湖南先施制药有限公司","否","否","通过一致性评价",485.4,"符合（通过一致性评价仿制药）","阳光目录","2025年第九批药品新增阳光挂网"]
["XA16AXL154A001010484106","硫辛酸片","片剂(薄膜衣片)","0.2g","口服固体药用聚酯含热封垫片瓶包装","片","盒",120,"国药准字H20253713","浙江赛默制药有限公司","湖南先施制药有限公司","否","否","通过一致性评价",946.55,"符合（通过一致性评价仿制药）","阳光目录","2025年第九批药品新增阳光挂网"]
["XJ02AXZ028A001010101884","制霉素片","片剂","50万IU","塑料瓶装","片","瓶",100,"国药准字H42021548","华中药业股份有限公司","华中药业股份有限公司","是","否","其他",38.9,"符合（性价比优）","阳光目录","2025年第九批药品新增阳光挂网"]
["ZA14BAB0244010201833","保和片","片剂","0.4g","塑料瓶","片","盒",36,"国药准字Z42021503","湖北民康制药有限公司","湖北民康制药有限公司","是","是","其他",39.8,"符合（性价比优）","阳光目录","2025年第九批药品新增阳光挂网"]
["XD06AXM119F001030105765","莫匹罗星软膏","软膏剂","2%(5g:0.1g)(每支10g)","铝管","支","盒",1,"国药准字H20193036","海南全星制药有限公司","海南全星制药有限公司","是","否","其他",18.81,"符合（性价比优）","阳光目录","2025年第九批药品新增阳光挂网"]
["XN05ADF085A001010203968","氟哌啶醇片","片剂","2mg","塑瓶","片","瓶",100,"国药准字H37021399","济南恒基制药有限公司","济南恒基制药有限公司","是","是","其他",20.8,"符合（性价比优）","阳光目录","2025年第九批药品新增阳光挂网"]
["XJ01CEQ055N001010202042","青霉素V钾颗粒","颗粒剂","0.118g(20万单位)","聚酯/铝/聚乙烯药用复合膜","袋","盒",8,"国药准字H20030726","四川制药制剂有限公司","四川邈济生物医药科技有限公司","是","否","其他",26.6,"符合（性价比优）","阳光目录","2025年第九批药品新增阳光挂网"]
["XJ01CEQ055N001010302042","青霉素V钾颗粒","颗粒剂","0.118g(20万单位)","聚酯/铝/聚乙烯药用复合膜","袋","盒",24,"国药准字H20030726","四川制药制剂有限公司","四川邈济生物医药科技有限公司","是","否","其他",79.8,"符合（性价比优）","阳光目录","2025年第九批药品新增阳光挂网"]
["XJ01CEQ055N001010402042","青霉素V钾颗粒","颗粒剂","0.118g(20万单位)","聚酯/铝/聚乙烯药用复合膜","袋","盒",12,"国药准字H20030726","四川制药制剂有限公司","四川邈济生物医药科技有限公司","是","否","其他",39.9,"符合（性价比优）","阳光目录","2025年第九批药品新增阳光挂网"]
["ZA12GAX0606010102230","心安胶囊","胶囊剂","每粒装0.3g(含总黄酮80mg)","药用PVC硬片/药品包装用PTP铝箔","粒","盒",36,"国药准字Z20054506","四川省仁德制药有限公司","四川省仁德制药有限公司","是","否","其他",23.76,"符合（性价比优）","阳光目录","2025年第九批药品新增阳光挂网"]
["XS01AXQ022G010010100315","盐酸羟苄唑滴眼液","滴眼剂","8ml:8mg(每瓶8ml)","塑料滴眼液瓶","瓶","盒",1,"国药准字H44024632","广东南国药业有限公司","广东南国药业有限公司","是","否","其他",20,"符合（性价比优）","阳光目录","2025年第九批药品新增阳光挂网"]
["XS01AEN076G010020103299","诺氟沙星滴眼液","滴眼液","8ml:24mg","塑料滴眼剂瓶","支","盒",1,"国药准字H22020413","长春长庆药业集团有限公司","长春长庆药业集团有限公司","是","否","其他",4.5,"符合（性价比优）","阳光目录","2025年第九批药品新增阳光挂网"]
["ZA04AAN0110010201072","牛黄解毒胶囊","硬胶囊","每粒装0.4g(人工牛黄)","药品包装用PTP铝箔和药用PVC硬片复合包装","粒","盒",40,"国药准字Z19980107","重庆芸峰药业有限公司","重庆芸峰药业有限公司","是","否","其他",34.78,"符合（性价比优）","阳光目录","2025年第九批药品新增阳光挂网"]
["ZI01AAE0071010105750","二十五味驴血丸","丸剂","每丸重0.25g","铝塑泡罩","丸","盒",54,"国药准字Z54020150","西藏雄巴拉曲神水藏药有限公司","西藏雄巴拉曲神水藏药有限公司","是","否","其他",78,"符合（性价比优）","阳光目录","2025年第九批药品新增阳光挂网"]
["ZI01AAE0060010105750","二十味沉香丸","丸剂","每10丸重5.6g","铝塑泡罩","丸","盒",48,"国药准字Z54020149","西藏雄巴拉曲神水藏药有限公司","西藏雄巴拉曲神水藏药有限公司","是","否","其他",73.15,"符合（性价比优）","阳光目录","2025年第九批药品新增阳光挂网"]
["XB05BBP072B002010105952","葡萄糖注射液","注射剂","100ml:10g","三层共挤输液用膜制袋","袋","袋",1,"国药准字H20103454","青海夏都医药有限公司","青海夏都医药有限公司","是","是","其他",1.83,"符合（性价比优）","阳光目录","2025年第九批药品新增阳光挂网"]
["XR06AXD078K001030101442","地氯雷他定糖浆","糖浆剂","120ml:60mg","口服液体药用聚酯瓶","瓶","盒",1,"国药准字H20183211","江苏广承药业有限公司","江苏广承药业有限公司","是","否","其他",50.66,"符合（性价比优）","阳光目录","2025年第九批药品新增阳光挂网"]
["ZA03AAT0182010109198","通便灵胶囊","胶囊剂","每粒装0.25g","铝塑泡罩包装","粒","盒",20,"国药准字Z20053170","吉林省益浦生物科技有限公司","吉林省益浦生物科技有限公司","是","是","其他",11,"符合（性价比优）","阳光目录","2025年第九批药品新增阳光挂网"]
["XC04AXF029A017010100269","盐酸酚苄明片","片剂(薄膜衣)","10mg","铝塑包装","片","盒",24,"国药准字H44021427","广东彼迪药业有限公司","广东彼迪药业有限公司","是","否","其他",9.24,"符合（性价比优）","阳光目录","2025年第九批药品新增阳光挂网"]
["XD01AEH035F002020103087","环吡酮胺乳膏","乳膏剂","20g:0.2g","药用聚乙烯/铝/聚乙烯复合软膏管","支","盒",1,"国药准字H10900042","许昌未来制药有限责任公司","许昌未来制药有限责任公司","是","是","其他",15.77,"符合（性价比优）","阳光目录","2025年第九批药品新增阳光挂网"]
["XB05BBP072B002010203204","葡萄糖注射液","注射剂","20ml:10g","低硼硅玻璃安瓿","支","支",1,"国药准字H41023719","遂成药业股份有限公司","遂成药业股份有限公司","是","是","其他",0.59,"符合（性价比优）","阳光目录","2025年第九批药品新增阳光挂网"]
["XJ05ABA075N001010104483","阿昔洛韦颗粒","颗粒剂","0.2g","复合膜","袋","盒",10,"国药准字H10940206","杭州益品新五丰药业有限公司","杭州益品新五丰药业有限公司","是","否","其他",32.8,"符合（性价比优）","阳光目录","2025年第九批药品新增阳光挂网"]
["XJ01XDT146B002010604098","替硝唑氯化钠注射液","注射剂","100ml:替硝唑0.4g与氯化钠0.9g","聚丙烯输液瓶","瓶","瓶",1,"国药准字H20023662","山东华鲁制药有限公司","山东华鲁制药有限公司","是","否","其他",4.11,"符合（性价比优）","阳光目录","2025年第九批药品新增阳光挂网"]
["ZA06BCX0536020202353","小儿宣肺止咳颗粒","颗粒剂","每袋装2.67g(每1g相当于饮片1.79g)","聚酯/铝/聚乙烯药用复合膜包装","袋","盒",15,"国药准字Z20054203","陕西白鹿制药股份有限公司","陕西白鹿制药股份有限公司","是","否","其他",44.98,"符合（性价比优）","阳光目录","2025年第九批药品新增阳光挂网"]
["XR06AAL231X001020100371","富马酸氯马斯汀口服溶液","口服溶液剂","60ml:8.04mg(每瓶30ml)","口服液体药用高密度聚乙烯瓶","瓶","盒",1,"国药准字H20148003","广东众生药业股份有限公司","广东众生药业股份有限公司","否","否","其他",26.21,"符合（性价比优）","阳光目录","2025年第九批药品新增阳光挂网","专家论证结果"]
["XJ06AAA006B014020105897","注射用A型肉毒毒素","冻干粉针","每瓶含A型肉毒毒素100单位(U)","中性硼硅玻璃管制注射剂瓶,药用卤化丁基橡胶塞","瓶","瓶","1","国药准字S10970037","兰州生物技术开发有限公司","兰州生物技术开发有限公司","是","否","其他",660,"符合（性价比优）","阳光目录","2025年第九批药品新增阳光挂网"]
["XB03AAF611N001010605095","富马酸亚铁颗粒","颗粒剂","2g:0.2g","双向拉伸聚丙烯/镀铝聚酯/低密度聚乙烯药品包装用复合膜","袋","盒",20,"国药准字H45021056","恒拓集团南宁仁盛制药有限公司","恒拓集团南宁仁盛制药有限公司","是","否","其他",33.66,"符合（医保不同大类剂型）","阳光目录","2025年第九批药品新增阳光挂网"]
["XB03AAF611N001010505095","富马酸亚铁颗粒","颗粒剂","2g:0.2g","双向拉伸聚丙烯/镀铝聚酯/低密度聚乙烯药品包装用复合膜","袋","盒",18,"国药准字H45021056","恒拓集团南宁仁盛制药有限公司","恒拓集团南宁仁盛制药有限公司","是","否","其他",30.31,"符合（医保不同大类剂型）","阳光目录","2025年第九批药品新增阳光挂网"]
["ZI01AAS0658010105750","石榴健胃丸","丸剂","每10丸重6g","铝塑泡罩","丸","盒",48,"国药准字Z20023303","西藏雄巴拉曲神水藏药有限公司","西藏雄巴拉曲神水藏药有限公司","是","否","其他",68.66,"符合（医保不同大类剂型）","阳光目录","2025年第九批药品新增阳光挂网"]
["XS01BCY174G010010202585","吲哚美辛滴眼液","滴眼液","8ml:40mg","药用滴眼剂聚酯瓶","瓶","盒","1","国药准字H20000080","邯郸康业制药有限公司","邯郸康业制药有限公司","是","否","其他",98,"符合（医保不同大类剂型）","阳光目录","2025年第九批药品新增阳光挂网"]
["XS01LAB275B002010178679","布西珠单抗注射液","注射剂","预充式注射器装:19.8mg(0.165mL)/支","预充式注射器规格:1支预充式注射器/盒(120mg/mL,内含大于0.05mL布西珠单抗无菌溶液)。无菌溶液装于预充式注射器(I型玻璃)中,注射器配有溴化丁基橡胶柱塞和注射器帽盖,该帽盖由防篡改密封件","支","盒",1,"国药准字SJ20250020","Novartis Manufacturing NV","北京诺华制药有限公司","否","否","生物制剂创新药",6500,"符合（原研）","阳光目录","2025年第九批药品新增阳光挂网","专家论证结果"]